ethamsylate
Last reviewed 01/2018
Ethamsylate is believed to correct abnormal platelet adhesion, so reducing capillary bleeding.
It is licensed in short courses for reducing menorrhagia and also for the prophylaxis and treatment of periventricular haemorrhage in low birth weight infants.
It is contra-indicated in porphyria and may cause nausea, headaches and rashes.